Key result
Clinical management of maternal cardiac arrest relies largely on expert opinion and observational data due to a lack of randomized clinical trials.
Why the study?
Randomized clinical trials to guide the management of maternal cardiac arrest are lacking, despite increasing maternal mortality in the United States and emerging evidence of potential survival differences.
Answers are grounded in this paper and cite their sources.
Recent evidence suggests pregnant women may have higher survival rates following cardiac arrest compared to the general population, though management is currently guided by low-quality evidence.
(Am J Obstet Gynecol. 2018;219(1):52–61) Maternal mortality is complex and involves many factors, including comorbidities, access to health care, and racial, socioeconomic, and ethnic disparities. While the global maternal mortality ratio has declined, the maternal mortality ratio in the United States has increased over the last 25 years. The rate of survival of maternal cardiac arrest (MCA) has previously been seen as poor; however, new evidence suggests the pregnant population may have greater survival than others requiring cardiopulmonary resuscitation. This report reviewed techniques for the clinical management of MCA while highlighting existing knowledge gaps. As there is a lack of randomized clinical trials for guiding management of cardiac arrest during pregnancy, data for this review largely came from expert opinions, small case series, simulation studies, and cohort studies.
No takes yet. Share an insight, caveat, or question.
Zelop et al. (2019) conducted a review in Maternal cardiac arrest. Clinical management of maternal cardiac arrest was evaluated. Clinical management of maternal cardiac arrest relies largely on expert opinion and observational data due to a lack of randomized clinical trials.
Synapse has enriched 10 related papers. Consider them for comparative context: